The present invention relates to a pharmaceutical composition comprising at least one compound of formula (I)whereinR1 denotes e.g. hydrogen or straight chain C1-C6-alkyl,R2 and R3 denote e.g. hydrogen or straight chain C1-C6-alkyl,or a pharmaceutically acceptable salt thereof and at least one pharmaceutically acceptable excipient for use as a medicament for the treatment of inflammatory diseases or conditions, in particular T-cell mediated inflammatory diseases or conditions.
